Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tectonic Therapeutic, Inc. - Common Stock (NQ: TECX )

44.03 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 459
Open 44.03
Bid (Size) 26.60 (1)
Ask (Size) 50.00 (2)
Prev. Close 44.03
Today's Range 44.03 - 44.03
52wk Range 15.00 - 48.63
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire

Performance

YTD
+158.85%
+158.85%
1 Month
+19.32%
+19.32%
3 Month
+170.95%
+170.95%
6 Month
+158.85%
+158.85%
1 Year
+158.85%
+158.85%

More News

Read More
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
From Tectonic Therapeutic
Via GlobeNewswire
TECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024
Via InvestorPlace
Tectonic Therapeutic to Participate in September Investor Conferences
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
From Tectonic Therapeutic
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.